Professional Summary
Eric McDuffie has more than 20 years of experience as a preclinical toxicologist in the pharmaceutical industry. In his current role as Director of Investigative Toxicology at Neurocrine Biosciences, Inc. in San Diego, CA, USA, he leads a dedicated team that supports neuroscience drug discovery and development programs. He joined Neurocrine in 2021, after a 14-year tenure at Janssen Research & Development, LLC in San Diego. At Janssen, he served as Senior Scientist and later as Director of Mechanistic & Investigative Toxicology. He had a prior 7-year tenure at Pfizer, Inc. in Ann Arbor & Plymouth, MI, USA, where he contributed to different functional groups as Senior Scientist/Manager for the Laboratory Core Group; the Investigative Pathology Group; and lastly, the Immunotoxicology Group. Eric has co-authored more than 40 peer reviewed manuscripts and delivered numerous platform presentations. Notably, he served as a co-editor for the benchmark book, Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers (2016).
Leave your rating